drugset / Trial / NCT00641212

Children, Perennial Allergic Rhinitis (PAR), l-t Growth

NCT00641212

Phase 4 Completed 209 enrolled AstraZeneca
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare the effect of Rhinocort nasal spray with placebo on growth in children with perennial allergic rhinitis over 12 months.

Timeline

Start
2000-01
Primary completion
2003-04
Completion
2003-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule Intranasal